LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

Gladius Capital Management LP's Holding History (CIK: 0001540656)

Note: Option positions (PUT/CALL) are excluded.

Q2 2023
Shares 6,956 Value ($000) $22 Avg Close — Range —
Q1 2023
Shares 10,997 Value ($000) $26 Avg Close — Range —